C. Le Pen et al., The long-term effectiveness of preventive strategies for osteoporosis in postmenopausal women: A modeling approach, OSTEOPOR IN, 11(6), 2000, pp. 524-532
Based on data from the literature, we have developed a computer-based simul
ation model to compare the long-term effectiveness of different preventive
strategies of osteoporotic fractures. The Markov model comprises 25 states,
including states which describe women distributed according to three level
s of fracture risk, fractures states, post-fracture states and a death stat
e. We chose eight standard preventive strategies, which we compare with the
'No Treatment' reference strategy. The first two strategies consist in tre
ating all 50-year-old women for 5 or 10 years with hormone replacement ther
apy (HRT). Strategies 3 and 4 aim at assessing a 5-year course of treatment
with bisphosphonates in osteopenic and osteoporotic 65- or 75-year-old wom
en. Strategies 5 and 6 combine 5 years of HRT in all 50-year-old women with
5 years of bisphosphonates in osteopenic and osteoporotic women at 65 or 7
5 years. The last two strategies simulate 10 years of HRT in all 50-year-ol
d women, followed by strategy 3 or strategy 4. Simulated life expectancy an
d mean ages of fracture occurrence fit well with the observed data. All the
preventive strategies tested reduced the number of fractures. Early 10-yea
r HRT in all women, plus 5 years of bisphosphonates in women at risk Of fra
ctures at 65 or 75 years, are the most effective strategies, with an 18.4-1
9.0% reduction in all fractures, and a 25.6-26.1% reduction in the number o
f hip fractures. Strategy 2 has a similar outcome, thus demonstrating the v
alue of treatment started early and sustained over a long period. The strat
egies implemented later, S3 and S4, only concern women at risk (i.e., osteo
penic or osteoporotic), and are less effective, with a 1.5-2.1% decrease in
all fractures. The combined strategies, S5 and S6, produce intermediate re
sults: a 12.9-13.5% reduction in the number of all fractures and a 17.5-17.
9% reduction in hip fractures.